[{"Assets_0_Q2_USD":59424000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-115000000.0,"NetIncomeLoss_1_Q2_USD":-689000000.0,"NetIncomeLoss_2_Q2_USD":-794000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1092000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1091000000.0,"StockholdersEquity_0_Q2_USD":14122000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.63,"EarningsPerShareBasic_2_Q2_USD":-0.73,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190807"}]